A
Amide Technologies
Accelerating drug development with rapid peptide synthesis and high-speed delivery
About Amide Technologies
AmideTech operates in the pharmaceutical and biotechnology sectors, specializing in the synthesis of complex peptides and proteins. The company serves pharmaceutical companies, research institutions, and biotech firms that require high-quality peptides for drug discovery and development. AmideTech's business model focuses on providing custom peptide synthesis services, including the production of long polyamides and full-length proteins. The company differentiates itself by accepting challenging orders that other vendors refuse and delivering them in less than a week, thus accelerating the drug development process. Revenue is generated through the sale of these specialized peptide synthesis services. AmideTech's competitive advantage lies in its ability to produce significantly longer peptides and its commitment to high-speed delivery, which is critical in the fast-paced world of drug discovery. The company also emphasizes a collaborative and transparent work culture, attracting highly motivated scientists and engineers to its team.
Source: Dealroom company dataAt a glance
- Founded
- 2017
- Headquarters
- Cambridge, United States
Latest news
Press, funding announcements and product moves mentioning Amide Technologies.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
- BVBiological Engineering Ventures
Series A2 investors entered at this stage
The Engine- FVForcefield Venture
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Amide Technologies on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Amide Technologies on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.